Furthermore, for non-alcoholic fatty liver disease, SIRT3 overexpression can protect liver cells by promoting BNIP3-mediated-mitophagy and reducing mitochondrial apoptosis, thus effectively treating non-alcoholic cirrhosis (Li et al., 2018). The gene discussed is SIRT3; the disease is alcoholic liver cirrhosis.